A dose-finding study of sufentanil sublingual microtablets for the management of postoperative bunionectomy pain

Journal of Trauma and Acute Care Surgery

Volumn 77, Issue 3 SUPPL. 2, 2014, Pages

  Singla, Neil K ^a   Muse, Derek D ^c   Evashenk, Mark A ^b   Palmer, Pamela P ^b  

^a Lotus Clinical Research   (United States)

^b AcelRx Pharmaceuticals   (United States)

^c Jean Brown Research   (United States)

Author keywords

context sensitive half time; plasmaYcentral nervous system equilibration half life; Therapeutic index

Indexed keywords

PLACEBO; SUFENTANIL; NARCOTIC ANALGESIC AGENT; TABLET;

ADULT; AGED; ARTICLE; BUNIONECTOMY; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HAMMER TOE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL MUCOSITIS; PAIN ASSESSMENT; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRESYNCOPE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TABLET; THORAX PAIN; VOMITING; XEROSTOMIA; CLINICAL TRIAL; HALLUX VALGUS; MIDDLE AGED; PAIN, POSTOPERATIVE; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; AGED; ANALGESICS, OPIOID; DOUBLE-BLIND METHOD; FEMALE; HALLUX VALGUS; HUMANS; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE; SUFENTANIL; TABLETS;

EID: 84907369711     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000373     Document Type: Article

References (14)

1. Lotsch J. Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Symptom Manage. 2005;29:S90-S103.
2. Mather LE. Opioids: A phamacologist's delight Clin Exp Pharmacol Physiol. 1995;22:833-836.
3. Bovill JG, Sebel PS, Blackburn CL, Oei-Lim V, Heykants JJ. The pharmacokinetics of sufentanil in surgical patients. Anesthesiology. 1984;61:502-506.
4. Gan TJ, Palmer PP, Royal MA. Optimizing an Opioid for PCA Delivery: TheClinical Importance ofCST2and t2ke0. San Francisco, CA: American Society of Anesthesiologists Annual Meeting; October 12-16, 2013.
5. Minkowitz HS, Singla NK, Evashenk MA, Hwang SS, Chiang YK, Hamel LG, Palmer PP. Pharmacokinetics of sublingual sufentanil tablets and efficacy and safety in the management of postoperative pain. Reg Anesth Pain Med. 2013;38:131-139.
6. Melson T, Boyer D, Minkowitz HS, Palmer PP, Royal MA. Sufentanil NanoTab PCA System Versus IV PCA Morphine for Post-operative Pain: A Randomized, Open-label, Active-comparator Trial. San Francisco, CA: American Society ofAnesthesiologists Annual Meeting; October 12-16, 2013.
7. Ringold FG, Minkowitz HS, Gan TJ, Aqua KA, Palmer PP, Royal MA. A Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg Plus Rescue Morphine Versus Placebo Plus Rescue Morphine in Patients With Moderate-To-Severe Pain After Open Abdominal Surgery. San Francisco, CA: American Society of Anesthesiologists Annual Meeting; October 12-16, 2013.
8. Minkowitz HS, Jove M, Griffin DW, Melson T, Palmer PP, Royal MA. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System for the Treatment of Post-operative Pain in Patients After Knee or Hip Replacement Surgery. San Francisco, CA: American Society of Anesthesiologists Annual Meeting; October 12-16, 2013.
9. Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377-390.
10. Garner-Nix J. Oral transmucosal fentanyl and sufentanil for incident pain. J Pain Symp Manag. 2001;22:627-630.
11. Mercadante S. The use of rapid onset opioids for breakthrough cancer pain: The challenge of its dosing. Crit Rev Oncol Hematol. 2011;80:460-465.
12. Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003;10:390-392.
13. Daniels S, Casson E, Stegmann JU, Oh C, Okamoto A, Rauschkolb C, Upmalis D. A randomized, double-blind, placebo-controlled Phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr Med Res Opin. 2009;25:1551-1561.
14. Lehmann KA, Gerhard A, Horrichs Haermeyer G, Grond S, Zech D. Postoperative patient-controlled analgesia with sufentanil: Analgesia efficacy and minimum effective concentrations. Acta Anaesthesiol Scand. 1991;35:221-226.